$TNDM News
Last published 6d ago
- 6d agoTNDMTANDEM DIABETES CARE INC - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 6d agoTNDMTandem Diabetes Care Q3 2026 Earnings - TANDEM DIABETES CARE INCEarnings Call TranscriptsGood day and welcome to the Tandem Diabetes Care Third Quarter 2026 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question and answer
- 1mo agoTNDMTandem Diabetes Care to Announce Third Quarter 2026 Financial Results on November 5, 2026Business WireTandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2026 results after the financial markets close on Thursday, November 5, 2026. The
- 1mo agoTNDMTandem Mobi Automated Insulin Delivery System Now Available in Twelve International MarketsBusiness WireTandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world’s smallest, durable automated insulin delivery system for people living
- 3mo agoTNDMCG 46TH ANNUAL GROWTH CONFERENCE - TANDEM DIABETES CARE INCEarnings Call TranscriptsMy name is Bill Plovonik. I'm a Senior Medical Device Analyst here at Canaccord. Welcome to our 46th Annual Global Growth Conference. With us up next, we have Tandem Diabetes, and for Tandems, we have Lee Vossler, CFO, a
- 3mo agoTNDMCG 46TH ANNUAL GROWTH CONFERENCE - TANDEM DIABETES CARE INCEarnings Call TranscriptsMy name is Bill Plovonik. I'm a Senior Medical Device Analyst here at Canaccord. Welcome to our 46th Annual Global Growth Conference. With us up next, we have Tandem Diabetes, and for Tandems, we have Lee Vossler, CFO, a
- 3mo agoTNDMTandem Diabetes Care Announces Second Quarter 2026 Financial ResultsBusiness WireTandem Diabetes Care, Inc. (NASDAQ:TNDM) (the Company), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2026. Second Quarter 2026
- 3mo agoTNDMTandem Diabetes Care Announces Upcoming Conference PresentationBusiness WireTandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at Canaccord Genuity’s 46th Annual Growth Conference
- 4mo agoTNDMTandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International MarketsBusiness WireCompatibility now available in five countries, with additional markets expected throughout 2026.Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced that
- 4mo agoTNDMTandem Diabetes Care to Announce Second Quarter 2026 Financial Results on August 6, 2026Business WireTandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2026 results after the financial markets close on Thursday, August 6, 2026. The
- 5mo agoTNDMTandem Diabetes Care Automated Insulin Delivery Systems Receive CE Mark for Type 2 Diabetes and Type 1 Diabetes During PregnancyBusiness WireTandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced receipt of CE mark for expanded indications of its automated insulin delivery (AID) systems in
- 6mo agoTNDMTandem Diabetes Care Announces First Quarter 2026 Financial ResultsBusiness WireTandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2026 and reaffirmed financial guidance for the
- 6mo agoTNDMTandem Diabetes Care Announces Upcoming Conference PresentationsBusiness WireTandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences: BofA
- 6mo agoTNDMTandem Diabetes Care's Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 DiabetesBusiness WireFirst and only commercially available AID technology for pregnancy use in the U.S. Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced that the United
- 7mo agoTNDMTandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 2026Business WireTandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2026 results after the financial markets close on Thursday, May 7, 2026. The
- 8mo agoTNDMTandem Mobi Now Compatible with Android SmartphonesBusiness WireTandem Diabetes Care expands connected-care ecosystem by adding Android platform Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today announced that Tandem Mobi,
- 8mo agoTNDMTandem Diabetes Care Prices Upsized Private Placement of $265 Million of Convertible Senior Notes Due 2032Business WireTandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, announced today the pricing of $265.0 million aggregate principal amount of 0.00% Convertible Senior Notes due 2032
- 8mo agoTNDMTandem Diabetes Care Announces Proposed Private Placement of Convertible NotesBusiness WireTandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, announced today that it intends to offer, subject to market conditions and other factors, $200.0 million aggregate
- 8mo agoTNDMTandem Diabetes Care Announces Fourth Quarter and Full Year 2025 Financial Results and 2026 Financial GuidanceBusiness WireTandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter and fiscal year ended December 31, 2025 and provided its
- 9mo agoTNDMTandem Diabetes Care Announces Upcoming Conference PresentationsBusiness WireTandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences: Citi's 2026
- 10mo agoNVOELDNVKTXTNDMThe End of Shots? 5 Biotech Stocks Rethinking DiabetesPR NewswireUSA News Group News Commentary – Recent clinical trials achieving 83% insulin independence rates have ignited a dramatic shift in metabolic disease...
- 10mo agoTNDMTandem t:slim Mobile App Now Available in CanadaBusiness WireTandem Diabetes Care, Inc. (NASDAQ:TNDM) a leading insulin delivery and diabetes technology company, today announced availability of the Tandem t:slim mobile application for Android and iOS users in Canada. The Tandem
- 12mo agoTNDMTandem Diabetes Care Announces Appointment of Sandra Beaver to Board of DirectorsBusiness WireTandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Sandra Beaver to its board of directors effective November 7, 2025. Ms. Beaver
- 1y agoTNDMTandem Mobi Receives FDA Clearance for Use with Android SmartphonesBusiness WireBy adding compatibility with the Android platform, Tandem Mobi is expanding its connected-care ecosystem Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today
- 1y agoTNDMTandem Diabetes Care Achieves ISO/IEC 27001:2022 Certification, Reinforcing Commitment to Global Data Security StandardsBusiness WireCertification affirms Tandem's company-wide commitment to cybersecurity, data protection, and operational integrity Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company,
- 1y agoTNDMTandem Diabetes Care Announces Upcoming Conference PresentationsBusiness WireTandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences: Stifel 2025
- 1y agoTNDMt:slim X2™ Insulin Pump Now Available with Abbott's FreeStyle Libre® 3 Plus Sensor in the United StatesBusiness WireTandem Diabetes Care begins global commercial rollout of t:slim X2 pump integration with the FreeStyle Libre 3 Plus CGM sensor, expanding choice and personalization for people living with diabetes worldwide Tandem
- 1y agoDXCMTNDMDexCom, Inc. vs Abbott Diabetes Care Inc. et al. - AIA Trial, DismissedUS Patent Trial and Appeal Board
- 1y agoTNDMTandem Diabetes Care to Announce Third Quarter 2025 Financial Results on November 6, 2025Business WireTandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2025 results after the financial markets close on Thursday, November 6, 2025. The
- 1y agoTNDMTandem Diabetes Care Announces Publication Showing Adults With Type 2 Diabetes Benefit from Automated Insulin Delivery Regardless of C-Peptide LevelsBusiness WireThis sub-analysis is the first study to evaluate AID outcomes for people with type 2 diabetes using the Center for Medicare and Medicaid Services (CMS) criteria for insulin pump coverage. Tandem Diabetes Care®
- 1y agoTNDMTandem Diabetes Care, Inc. (TNDM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptEarnings Call Transcripts
- 1y agoTNDMTandem t:slim Mobile App Now Authorized by Health Canada for iPhone and Android PhonesBusiness WireTandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced Health Canada authorization for distribution of the Tandem t:slim mobile application for Android and
- 1y agoTNDMTandem Diabetes Care Issues Voluntary Medical Device Correction for Select t:slim X2 Insulin PumpsBusiness WireTandem Diabetes Care, Inc. (NASDAQ:TNDM) has announced a voluntary medical device correction for select t:slim X2 insulin pumps to address a potential speaker-related issue that can trigger an error resulting in a
- 1y agoTNDMTandem Diabetes Care, Inc. (TNDM) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoTNDMTandem Diabetes Care Announces Second Quarter 2025 Financial Results and Provides 2025 Annual GuidanceBusiness WireTandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2025 and provided full year 2025
- 1y agoTNDMTandem Diabetes Care Announces Upcoming Conference ParticipationBusiness WireTandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced that management will host meetings and present a company update at the following investor
- 1y agoDXCMTNDMDexCom, Inc. vs Abbott Diabetes Care Inc. et al. - AIA Trial, DismissedUS Patent Trial and Appeal Board
- 1y agoDXCMTNDMDexCom, Inc. vs Abbott Diabetes Care Inc. et al. - AIA Trial, DismissedUS Patent Trial and Appeal Board
- 1y agoDXCMTNDMDexCom, Inc. vs Abbott Diabetes Care Inc. et al. - AIA Trial, DismissedUS Patent Trial and Appeal Board
- 1y agoDXCMTNDMDexCom, Inc. vs Abbott Diabetes Care Inc. et al. - AIA Trial, DismissedUS Patent Trial and Appeal Board
- 1y agoABTDXCMIRTCTNDMArtificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue OpportunityPR NewswireArtificial Intelligence (AI) algorithms are revolutionizing the way retina images are analyzed for detecting conditions such as age-related macular...
- 1y agoTNDMTandem Diabetes Care to Announce Second Quarter 2025 Financial Results on August 6, 2025Business WireTandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2025 results after the financial markets close on Wednesday, August 6, 2025. The
- 1y agoTNDMTandem Diabetes Care Announces t:slim X2™ Insulin Pump Compatibility with Abbott's FreeStyle Libre® 3 Plus Sensor in the United StatesBusiness WireTandem continues to build its technology ecosystem to expand choice and personalization for people living with diabetes Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology
- 1y agoAVAIMDTNVOPODD+1Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue OpportunitiesGlobeNewswirePALM BEACH, Fla., June 17, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The global diabetic retinopathy market has shown a consistent growth in recent years and is expected to continue for the coming
- 1y agoTNDMTandem Diabetes Care Announces Agreement with Abbott for Integration of Automated Insulin Delivery Systems with Future Glucose-Ketone SensorBusiness WireTandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced an agreement to develop and commercialize integrated diabetes solutions that combine Abbott's
- 1y agoTNDMTandem Diabetes Care Announces Upcoming Conference PresentationsBusiness WireTandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences: 2025 RBC
- 1y agoTNDMTandem Diabetes Care Announces First Quarter 2025 Financial ResultsBusiness WireTandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2025. First Quarter 2025 Highlights, Financial
- 1y agoTNDMTandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025Business WireTandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2025 results after the financial markets close on Wednesday, April 30, 2025. The
- 1y agoTNDMTandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 DiabetesBusiness Wire– Additional data presented at the 18th International Conference on Advanced Technologies & Treatments for Diabetes – Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology
- 1y agoTNDMTandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United StatesBusiness Wire– Enhanced features extend automated insulin delivery (AID) to people ages 2 years and older with type 1 diabetes and adults with type 2 diabetes – Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery